2m 2m 2m 2m 2m 2m 2m
Vertex Pharma (VRTX)
NASDAQ
$471.00+$0.28 (+0.06%)
Price as of Aug 03, 2026 7:59 PM EDT- $121.1BMarket Cap
- -0.33%1-Year Change
- BiotechnologyIndustry
Vertex Pharma (VRTX)
$471.00+$0.28 (+0.06%)
VRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $470.72 | ||
Change | -$6.38 (-1.34%) | ||
Open | $480.00 | ||
High | $483.36 | ||
Low | $468.14 | ||
Previous Close | $477.10 | ||
Volume | 1,510,457 | ||
30-Day Average Volume | 1,455,282 | ||
1-Week Change | -1.73% | ||
1-Month Change | -10.86% | ||
1-Year Change | -0.33% | ||
3-Year Change | 35.37% | ||
5-Year Change | 135.30% | ||
Fundamentals | |||
Shares Outstanding | 253.8M | ||
Total Assets | $26.5B | ||
Market Cap | $121.1B | ||
Enterprise Value | $115.6B | ||
Period: QTR TTM FY | |||
Revenue | $3.0B | ||
Net Income | $1.0B | ||
Free Cash Flow | $1.3B | ||
EBIT | $1.3B | ||
EBITDA | $1.3B | ||
Net Working Capital | $7.8B | ||
EPS | $4.02 | ||
Enterprise Value/EBITDA | 88 | ||
Enterprise Value/Revenue | 39 | ||
P/B | 6 | ||
P/E | 119 | ||
PEG | -9 | ||
Price/Free Cash Flow | 94 | ||
Price/Operating Cash Flow | 85 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue